PT  - JOURNAL ARTICLE
AU  - Hamilton, I
AU  - O'Connor, H J
AU  - Wood, N C
AU  - Bradbury, I
AU  - Axon, A T
TI  - Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.
AID  - 10.1136/gut.27.1.106
DP  - 1986 Jan 01
TA  - Gut
PG  - 106--110
VI  - 27
IP  - 1
4099  - http://gut.bmj.com/content/27/1/106.short
4100  - http://gut.bmj.com/content/27/1/106.full
SO  - Gut1986 Jan 01; 27
AB  - Eighty patients with duodenal ulcer were randomly allocated to treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine. Ulcers healed in 78% of patients treated with TDB and in 74% treated with cimetidine, supporting previous observations that the efficacy of these two agents is similar. Duodenal ulcer recurred in 43% of patients in the 12 months after treatment with TDB and in 78% of patients treated with cimetidine, with a significantly greater incidence of recurrence 6-12 months after cimetidine treatment. Tripotassium dicitrato bismuthate tablets may be preferable to cimetidine in the initial management of duodenal ulcer, because they offer a smaller likelihood of recurrence in the 12 months after successful treatment.